|
|
Blood, 15 March 2006, Vol. 107, No. 6, pp. 2423-2431.
Prepublished online as a Blood First Edition Paper on November 17, 2005; DOI 10.1182/blood-2005-07-2709.
Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells
Tomoki Ito,
Holger Kanzler,
Omar Duramad,
Wei Cao, and
Yong-Jun Liu
From the Department of Immunology and Center for Cancer Immunology Research, The University of Texas M.D. Anderson Cancer Center, Houston, TX; and DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA.
Recent studies suggest plasmacytoid predendritic cells (pDCs) and myeloid dendritic cells (mDCs) have the functional plasticity to produce similar amounts of type 1 interferons (IFNs) and interleukin-12 (IL-12), challenging the concept and existence of DC subsets with distinct function. In this study, we demonstrate that previous studies showed human pDCs produce large amounts of IL-12 because of contaminating mDCs. Using highly purified human DC subsets, we found that although pDCs make 300 times more IFN- than mDCs and mDCs make 13 times more IL-12 p70 than pDCs in response to all the toll-like receptor ligands and CD40 ligands, pDCs rapidly make large amounts of IFN- within the first 12 hours of activation and become refractory to further stimulation. pDCs preferentially expressed the transcriptional factors critical for type 1 IFN, but not for IL-12 transcription, and they dedicated 60% of new transcriptional activity to make 19 type 1 IFN subtypes. This study provides formal proof that the plasticity of DC subsets is limited and that different DC subsets evolve to perform distinct functions in linking innate and adaptive immunity. (Blood. 2006;107:2423-2431)

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. G. Molenkamp, B. J.R. Sluijter, P. A.M. van Leeuwen, S. J.A.M. Santegoets, S. Meijer, P. G.J.T.B. Wijnands, J. B.A.G. Haanen, A. J.M. van den Eertwegh, R. J. Scheper, and T. D. de Gruijl
Local Administration of PF-3512676 CpG-B Instigates Tumor-Specific CD8+ T-Cell Reactivity in Melanoma Patients
Clin. Cancer Res.,
July 15, 2008;
14(14):
4532 - 4542.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Meyer-Wentrup, D. Benitez-Ribas, P. J. Tacken, C. J. A. Punt, C. G. Figdor, I. J. M. de Vries, and G. J. Adema
Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-{alpha} production
Blood,
April 15, 2008;
111(8):
4245 - 4253.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fiorentini, E. Riboldi, F. Facchetti, M. Avolio, M. Fabbri, G. Tosti, P. D. Becker, C. A. Guzman, S. Sozzani, and A. Caruso
HIV-1 matrix protein p17 induces human plasmacytoid dendritic cells to acquire a migratory immature cell phenotype
PNAS,
March 11, 2008;
105(10):
3867 - 3872.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Veckman and I. Julkunen
Streptococcus pyogenes activates human plasmacytoid and myeloid dendritic cells
J. Leukoc. Biol.,
February 1, 2008;
83(2):
296 - 304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Zucchini, G. Bessou, S. H. Robbins, L. Chasson, A. Raper, P. R. Crocker, and M. Dalod
Individual plasmacytoid dendritic cells are major contributors to the production of multiple innate cytokines in an organ-specific manner during viral infection
Int. Immunol.,
January 1, 2008;
20(1):
45 - 56.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Decalf, S. Fernandes, R. Longman, M. Ahloulay, F. Audat, F. Lefrerre, C. M. Rice, S. Pol, and M. L. Albert
Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients
J. Exp. Med.,
October 1, 2007;
204(10):
2423 - 2437.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Marshall, D. S. Heeke, M. L. Gesner, B. Livingston, and G. Van Nest
Negative regulation of TLR9-mediated IFN-{alpha} induction by a small-molecule, synthetic TLR7 ligand
J. Leukoc. Biol.,
September 1, 2007;
82(3):
497 - 508.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. G. Molenkamp, P. A.M. van Leeuwen, S. Meijer, B. J.R. Sluijter, P. G.J.T.B. Wijnands, A. Baars, A. J.M. van den Eertwegh, R. J. Scheper, and T. D. de Gruijl
Intradermal CpG-B Activates Both Plasmacytoid and Myeloid Dendritic Cells in the Sentinel Lymph Node of Melanoma Patients
Clin. Cancer Res.,
May 15, 2007;
13(10):
2961 - 2969.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. O. Kvale, Y. Floisand, F. Lund-Johansen, H. Rollag, L. Farkas, S. Ghanekar, P. Brandtzaeg, F. L. Jahnsen, and J. Olweus
Plasmacytoid DCs regulate recall responses by rapid induction of IL-10 in memory T cells
Blood,
April 15, 2007;
109(8):
3369 - 3376.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Berghofer, G. Haley, T. Frommer, G. Bein, and H. Hackstein
Natural and Synthetic TLR7 Ligands Inhibit CpG-A- and CpG-C-Oligodeoxynucleotide-Induced IFN-{alpha} Production
J. Immunol.,
April 1, 2007;
178(7):
4072 - 4079.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Faith, E. Peek, J. McDonald, Z. Urry, D. F. Richards, C. Tan, G. Santis, and C. Hawrylowicz
Plasmacytoid Dendritic Cells from Human Lung Cancer Draining Lymph Nodes Induce Tc1 Responses
Am. J. Respir. Cell Mol. Biol.,
March 1, 2007;
36(3):
360 - 367.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ito, M. Yang, Y.-H. Wang, R. Lande, J. Gregorio, O. A Perng, X.-F. Qin, Y.-J. Liu, and M. Gilliet
Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand
J. Exp. Med.,
January 22, 2007;
204(1):
105 - 115.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hosmalin and P. Lebon
Type I interferon production in HIV-infected patients
J. Leukoc. Biol.,
November 1, 2006;
80(5):
984 - 993.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Cao, D. B. Rosen, T. Ito, L. Bover, M. Bao, G. Watanabe, Z. Yao, L. Zhang, L. L. Lanier, and Y.-J. Liu
Plasmacytoid dendritic cell-specific receptor ILT7-Fc{varepsilon}RI{gamma} inhibits Toll-like receptor-induced interferon production
J. Exp. Med.,
June 12, 2006;
203(6):
1399 - 1405.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |